Total
0
Shares
Advance NanoTek (ASX:ANO) - Managing Director, Geoff Acton - The Market Herald
Managing Director, Geoff Acton
Sourced: Advance NanoTek
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Advance Nanotek (ANO) has teamed up with Astivita (AIR) to create an antimicrobial hand, face and body moisturiser
  • The moisturiser will include SPF15, with a percentage of zinc and hinokitiol
  • The companies have filed for a joint patent application
  • There is no claims this product with cure or stop contracting COVID-19
  • However, the product has been sent to MSL Solution to test its effectiveness against the virus
  • On market close, Advance Nanotek is up 1.18 per cent and is trading for $4.30, while Astivita remains unchanged, trading for 70 cents apiece

Advance Nanotek (ANO) has teamed up with Astivita (AIR) to create an antimicrobial hand, face and body moisturiser.

In their bid to create the products and get them on the market, the companies have filed a joint patent application.

The moisturiser will include SPF15, which has a percentage of zinc and hinokitiol.

The Advance Nanotek board has stated there are no claims that this product will cure COVID-19 or prevent the virus being contracted. However, the product has been sent to MSL Solutions to test its effectiveness against COVID-19.

How does this test work? Well, the product is tested against the feline coronavirus which is the 'surrogate' for COVID-19.

The results won't be received for some weeks.

For the 2020 financial year, the company said revenue will not be impacted by these products and cannot yet predict what impact there'll be, if any, for the 2021 financial year.

In March, Advance Nanotek released an announcement regarding a patent application, which saw the company's shares being suspended for a prolonged period.

"Although the Board doesn’t necessarily agree with the market relevance of the questions or the responses to those questions, the Board is eager to avoid a further unnecessary suspension," the company said.

Due to this, the company went into detail about the patent in its announcement.

On market close, Advance Nanotek is up 1.18 per cent and is trading for $4.30, while Astivita remains unchanged, trading for 70 cents apiece.

ANO by the numbers
More From The Market Herald
Synlait Milk (ASX:SM1) - CEO, John Penno - The Market Herald

" Synlait Milk (ASX:SM1) agrees to new funding arrangements

Synlait Milk (SM1) has agreed to new funding arrangements to refinance its maturing syndicated banking facilities.
Audio Pixels (ASX:AKP) completes speaker wafer testing

" Audio Pixels (ASX:AKP) readies technology for in-person demonstrations

Digital loudspeaker developer, Audio Pixels (AKP) has announced it is continuing to upgrade its demonstration systems by incorporating recently packaged transducers.
Fiji Kava (ASX:FIJ)- Founder and Managing Director, Mr Zane Yoshida - The Market Herald

" Fiji Kava (ASX:FIJ) partners with Chemist Warehouse for kava distribution

Fiji Kava (FIJ) has partnered with Chemist Warehouse to expand its presence in Australia, New Zealand and Ireland.
Harris Technology (ASX:HT8) - CEO, Garrison Huang - The Market Herald

" Harris Technology Group (ASX:HT8) ends June with $12.6m worth of sales

Harris Technology Group (HT8) has ended June with a record $12.56 million worth of sales, helped along by another bumper Amazon Prime Da…